Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 19 Sept 2023 for Hepion Pharmaceuticals, Inc., €8,380. Read the official filing
Filing timeline
BuySaleRobert T. Foster
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
Closed purchases
Market purchases
2
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Robert T. Foster: trading record in brief
Robert T. Foster is a declared insider of Hepion Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 15 September 2023 to 18 September 2023, the count stands at 2 filings.
No open-market sale appears; the market trades are 2 purchases worth €17k. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The record was last updated on 19 September 2023 with an open-market purchase (€8,380) in Hepion Pharmaceuticals, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Robert T. Foster
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
1,600 shares@ US$5.6050.8% of flowCommon StockSEC:0001104659-23-101784:0
Canonical exit: 17 Dec 2023 (T+90)
1,600 shares@ US$5.4049.2% of flowCommon StockSEC:0001104659-23-101391:0
Canonical exit: 14 Dec 2023 (T+90)
2 of 2 declarations
